vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and RED RIVER BANCSHARES INC (RRBI). Click either name above to swap in a different company.
AbCellera Biologics Inc. is the larger business by last-quarter revenue ($44.9M vs $33.2M, roughly 1.4× RED RIVER BANCSHARES INC). RED RIVER BANCSHARES INC runs the higher net margin — 34.4% vs -19.9%, a 54.3% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 15.7%). RED RIVER BANCSHARES INC produced more free cash flow last quarter ($42.2M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 12.4%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
Red River Bancshares Inc is a U.S. regional financial holding company operating through its wholly owned subsidiary Red River Bank. It provides a full suite of retail and commercial banking products including deposit accounts, personal and commercial loans, mortgage services, and wealth management, primarily serving customers across Louisiana, with a focus on local communities and small to mid-sized enterprises.
ABCL vs RRBI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $33.2M |
| Net Profit | $-8.9M | $11.4M |
| Gross Margin | — | — |
| Operating Margin | -63.7% | 42.8% |
| Net Margin | -19.9% | 34.4% |
| Revenue YoY | 788.4% | 15.7% |
| Net Profit YoY | 73.9% | 22.7% |
| EPS (diluted) | $-0.03 | $1.72 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $33.2M | ||
| Q3 25 | $9.0M | $31.9M | ||
| Q2 25 | $17.1M | $30.5M | ||
| Q1 25 | $4.2M | $29.9M | ||
| Q4 24 | $5.0M | $28.7M | ||
| Q3 24 | $6.5M | $27.9M | ||
| Q2 24 | $7.3M | $26.9M | ||
| Q1 24 | $10.0M | $26.3M |
| Q4 25 | $-8.9M | $11.4M | ||
| Q3 25 | $-57.1M | $10.8M | ||
| Q2 25 | $-34.7M | $10.2M | ||
| Q1 25 | $-45.6M | $10.4M | ||
| Q4 24 | — | $9.3M | ||
| Q3 24 | $-51.1M | $8.8M | ||
| Q2 24 | $-36.9M | $8.0M | ||
| Q1 24 | $-40.6M | $8.2M |
| Q4 25 | -63.7% | 42.8% | ||
| Q3 25 | -851.8% | 41.9% | ||
| Q2 25 | -290.2% | 41.7% | ||
| Q1 25 | -1479.6% | 43.0% | ||
| Q4 24 | — | 40.2% | ||
| Q3 24 | -1439.4% | 38.8% | ||
| Q2 24 | -1276.2% | 36.8% | ||
| Q1 24 | -551.5% | 38.5% |
| Q4 25 | -19.9% | 34.4% | ||
| Q3 25 | -637.8% | 33.8% | ||
| Q2 25 | -203.3% | 33.4% | ||
| Q1 25 | -1077.2% | 34.6% | ||
| Q4 24 | — | 32.4% | ||
| Q3 24 | -785.4% | 31.4% | ||
| Q2 24 | -504.3% | 29.7% | ||
| Q1 24 | -408.0% | 31.1% |
| Q4 25 | $-0.03 | $1.72 | ||
| Q3 25 | $-0.19 | $1.63 | ||
| Q2 25 | $-0.12 | $1.51 | ||
| Q1 25 | $-0.15 | $1.52 | ||
| Q4 24 | — | $1.36 | ||
| Q3 24 | $-0.17 | $1.27 | ||
| Q2 24 | $-0.13 | $1.16 | ||
| Q1 24 | $-0.14 | $1.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | $213.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $966.9M | $365.1M |
| Total Assets | $1.4B | $3.4B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | $213.4M | ||
| Q3 25 | $83.2M | $161.1M | ||
| Q2 25 | $92.4M | $210.4M | ||
| Q1 25 | $159.3M | $252.2M | ||
| Q4 24 | $156.3M | $269.0M | ||
| Q3 24 | $126.6M | $232.6M | ||
| Q2 24 | $148.3M | $213.1M | ||
| Q1 24 | $123.6M | $229.8M |
| Q4 25 | $966.9M | $365.1M | ||
| Q3 25 | $964.0M | $351.3M | ||
| Q2 25 | $1.0B | $335.4M | ||
| Q1 25 | $1.0B | $333.3M | ||
| Q4 24 | $1.1B | $319.7M | ||
| Q3 24 | $1.1B | $324.3M | ||
| Q2 24 | $1.1B | $307.0M | ||
| Q1 24 | $1.1B | $299.3M |
| Q4 25 | $1.4B | $3.4B | ||
| Q3 25 | $1.4B | $3.2B | ||
| Q2 25 | $1.4B | $3.2B | ||
| Q1 25 | $1.3B | $3.2B | ||
| Q4 24 | $1.4B | $3.1B | ||
| Q3 24 | $1.4B | $3.1B | ||
| Q2 24 | $1.4B | $3.0B | ||
| Q1 24 | $1.5B | $3.1B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $44.8M |
| Free Cash FlowOCF − Capex | $-44.6M | $42.2M |
| FCF MarginFCF / Revenue | -99.4% | 127.2% |
| Capex IntensityCapex / Revenue | 21.9% | 7.8% |
| Cash ConversionOCF / Net Profit | — | 3.92× |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | $75.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | $44.8M | ||
| Q3 25 | $-52.6M | $16.5M | ||
| Q2 25 | $-32.4M | $3.8M | ||
| Q1 25 | $-11.6M | $13.9M | ||
| Q4 24 | $-108.6M | $38.3M | ||
| Q3 24 | $-28.9M | $17.4M | ||
| Q2 24 | $-30.0M | $2.4M | ||
| Q1 24 | $-41.7M | $14.4M |
| Q4 25 | $-44.6M | $42.2M | ||
| Q3 25 | $-61.5M | $15.8M | ||
| Q2 25 | $-45.8M | $3.5M | ||
| Q1 25 | $-22.2M | $13.7M | ||
| Q4 24 | $-187.0M | $33.4M | ||
| Q3 24 | $-47.4M | $17.0M | ||
| Q2 24 | $-50.1M | $1.4M | ||
| Q1 24 | $-65.8M | $13.4M |
| Q4 25 | -99.4% | 127.2% | ||
| Q3 25 | -687.0% | 49.6% | ||
| Q2 25 | -267.9% | 11.6% | ||
| Q1 25 | -524.0% | 45.7% | ||
| Q4 24 | -3702.8% | 116.5% | ||
| Q3 24 | -728.4% | 60.9% | ||
| Q2 24 | -683.8% | 5.4% | ||
| Q1 24 | -661.5% | 50.8% |
| Q4 25 | 21.9% | 7.8% | ||
| Q3 25 | 99.7% | 2.1% | ||
| Q2 25 | 78.2% | 0.9% | ||
| Q1 25 | 251.1% | 0.9% | ||
| Q4 24 | 1552.7% | 17.0% | ||
| Q3 24 | 284.6% | 1.4% | ||
| Q2 24 | 274.6% | 3.6% | ||
| Q1 24 | 242.5% | 4.0% |
| Q4 25 | — | 3.92× | ||
| Q3 25 | — | 1.53× | ||
| Q2 25 | — | 0.37× | ||
| Q1 25 | — | 1.34× | ||
| Q4 24 | — | 4.11× | ||
| Q3 24 | — | 1.99× | ||
| Q2 24 | — | 0.30× | ||
| Q1 24 | — | 1.76× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
